Breast Cancer Subtype Characterization Through Patient's Derived Organoids.
Recruiting
Observational Study
Breast Cancer
Organoids
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 70
- Sex
- Any
- Study type
- Observational
- Participants needed
- 306 (estimated)
- Sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Development of tools to predict patients chemo-sensitivity and identification of corresponding biomarkers is an urgent challenge for BC patients lacking targeted therapies, such as TNBC, or for patients experiencing relapse after adjuvant chemotherapy or targeted therapies.
The refinement of 3D-cultivation techniques, experienced in the last decade, has allowed cultivation of patients-derived can…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* women diagnosed with primary BC, eligible for surgical resection of the tumor according to national and international guidelines.
age between 18 and 70 years; newly diagnosed breast neoplasms, tumor size of at least 1.5 cm diameter.
Exclusion Criteria:
breast cancer diagnos…
Contacts